Separately, Genvec has also been testing skeletal myoblast cell therapy in heartfailure patients, recently completing a 28-patient-trial led by Arizona Heart Institute cardiologist Nabil Dib.
Dr. Alan Colman, a member of the team that cloned Dolly the sheep -- the first cloned mammal -- in 1997, told CNN that within 20 years stem cell therapies could be used to treat degenerative diseases such as diabetes, congestive heartfailure and Parkinson's disease.